Covalis Capital’s Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 JWSM.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-74,998
Closed -$333K 91
2021
Q4
$333K Hold
74,998
0.12% 59
2021
Q3
$340K Hold
74,998
0.08% 83
2021
Q2
$350K Buy
+74,998
New +$86.1K 0.11% 82

Other funds holding JWSM.WS

Covalis Capital's JWSM.WS Position: Q1 2022 in Review

Covalis Capital sold out of Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (JWSM.WS) in Q1 2022, closing a stake of 74,998 shares — an estimated $333K sold.

Covalis Capital first reported a position in JWSM.WS in Q2 2021 and held it in 3 quarters. The position peaked at $350K in Q2 2021. 82 funds tracked by Wall St. Rank hold JWSM.WS as of Q1 2022.

  • Covalis Capital reported no remaining Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • Covalis Capital sold 74,998 Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $333K.
  • Covalis Capital first reported a position in Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 3 quarters.
  • Covalis Capital's Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $350K in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on Covalis Capital's 13F filing for Q1 2022, filed 16 May 2022.